Literature DB >> 33570578

Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by US Retail Pharmacies During the Pandemic.

Andrew I Geller1, Maribeth C Lovegrove1, Jennifer N Lind1, S Deblina Datta1, Daniel S Budnitz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33570578      PMCID： PMC7879382          DOI： 10.1001/jamainternmed.2021.0299

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  4 in total

1.  Association of County-Level Prescriptions for Hydroxychloroquine and Ivermectin With County-Level Political Voting Patterns in the 2020 US Presidential Election.

Authors:  Michael L Barnett; Marema Gaye; Anupam B Jena; Ateev Mehrotra
Journal:  JAMA Intern Med       Date:  2022-04-01       Impact factor: 21.873

2.  Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia.

Authors:  Andrea L Schaffer; David Henry; Helga Zoega; Julian H Elliott; Sallie-Anne Pearson
Journal:  PLoS One       Date:  2022-06-15       Impact factor: 3.752

3.  Uptake of Outpatient Monoclonal Antibody Treatments for COVID-19 in the United States: a Cross-Sectional Analysis.

Authors:  Timothy S Anderson; Ashley L O'Donoghue; Tenzin Dechen; Oren Mechanic; Jennifer P Stevens
Journal:  J Gen Intern Med       Date:  2021-09-08       Impact factor: 6.473

Review 4.  Health, financial and environmental impacts of unnecessary vitamin D testing: a triple bottom line assessment adapted for healthcare.

Authors:  Matilde Breth-Petersen; Katy Bell; Kristen Pickles; Forbes McGain; Scott McAlister; Alexandra Barratt
Journal:  BMJ Open       Date:  2022-08-23       Impact factor: 3.006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.